and 99mTc maraciclatide (1.62 vs. 1.41, p = 0.23), but the difference did not reach significance.
Amplitudes of n1-p1 were lower than in other groups, but the difference did not reach statistical significance.
Median hospital length of stay was decreased by 2 days, but the difference did not reach statistical significance (Table 3).
11C-vinpocetine binding potential was greater in the peri-infarcted zone than in the ischaemic core, but the difference did not prove to be significant [32, 33].
We observed fewer withdrawal's symptoms (14 vs 24%%, p = 0.09) in the period "after," but the difference did not reach statistical significance.
Effective dose was higher in females (0.064 mSv/MBq) relative to males (0.036 mSv/MBq), but the difference did not reach statistical significance (p = 0.08).
The uptake in the whole aorta was higher in LDLR -/- ApoB100/100 mice than in control mice, but the difference did not reach statistical significance.
Mean amplitudes of n1-p1 were lower than in the other groups, but the difference did not reach statistical significance (Table 3).
Peak severity scores were lower in the CCR2-null mice, but the difference did not reach statistical significance (p = 0.11).
Plasma cholesterol was elevated slightly, but the difference did not achieve statistical significance with the limited number of individuals.
Finger flexion also improved but the difference did not reach statistical significance.
